Grown Rogue International (GRUSF) Deferred Taxes (2023 - 2026)
Grown Rogue International's (GRUSF) quarterly Deferred Taxes came in at -$421318.0 in Q1 2026, down 564.35% year-on-year from $90732.7 in Q1 2025, and down 100.0% quarter-over-quarter from $66.6 billion in Q4 2025.
Grown Rogue International (GRUSF) Deferred Taxes (2023 - 2026) Analysis & Trends
Grown Rogue International's Deferred Taxes history runs 4 years deep, the most recent figure standing at -$421318.0 for Q1 2026.
- On a quarterly basis, Deferred Taxes fell 564.35% year-over-year to -$421318.0 in Q1 2026; TTM through Mar 2026 was -$1.2 million, a 1343.03% decrease from a year earlier, with the FY2025 full-year figure at -$830655.0, down 640.35% from the prior year.
- Deferred Taxes eased to -$421318.0 in Q1 2026 per GRUSF's latest filing, from $66.6 billion in the prior quarter.
- Across five years, Deferred Taxes topped out at $453.9 billion in Q4 2024 and bottomed at -$453.9 billion in Q3 2024.
- The 4-year median for Deferred Taxes is -$93251.0 (2024), against an average of -$187144.8.
- Across the five-year window, Deferred Taxes soared 202563156.9% in 2024 and sank 564.35% in 2026, its largest moves.
- Year by year, Deferred Taxes stood at -$224064.0 in 2023, then surged by 202563156.9% to $453.9 billion in 2024, then sank by 85.32% to $66.6 billion in 2025, then sank by 100.0% to -$421318.0 in 2026.
- Per Business Quant, the three latest GRUSF Deferred Taxes figures stand at -$421318.0 (Q1 2026), $66.6 billion (Q4 2025), and -$66.6 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | -421,318.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -421,318.00 |
| Dec 31, 2025 | 66.62 Bn |
| Sep 30, 2025 | -66.62 Bn |
| Jun 30, 2025 | -3,203.00 |
| Mar 31, 2025 | -63,418.00 |
| Dec 31, 2024 | 453.87 Bn |
| Sep 30, 2024 | -453.87 Bn |
| Jun 30, 2024 | -51,920.00 |
| Mar 31, 2024 | -93,251.00 |
| Dec 31, 2023 | -224,064.00 |
| Oct 31, 2023 | -470,358.00 |